Why Hedge Funds Like Mead Johnson Nutrition
Market Folly submits:
In our hedge fund portfolio tracking series we noticed that quite a few long/short equity funds added shares of Mead Johnson Nutrition (MJN) in the fourth quarter of 2009. In a recent letter to investors, Dan Loeb explained the rationale behind his hedge fund Third Point’s position in MJN and we thought this would be a perfect time to examine just why so many hedgies are fond of this company.
Mead Johnson Nutrition (MJN) completely separated from Bristol-Myers Squibb (BMY) in December of 2009. MJN is a leading infant formula producer and carries the well known brand Enfamil, making it a definitive consumer staples play.
Investing, Long Term Investment, stock market | admin March 8, 2010
RSS feed for comments on this post.
